1h Free Analyst Time
Global Hepatitis B Vaccines Market 2020-2024Speak directly to the analyst to clarify any post sales queries you may have.
The hepatitis b vaccines market is poised to grow by $ 524.00 mn during 2020-2024, progressing at a CAGR of 4% during the forecast period. The report on the hepatitis B vaccines market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the high prevalence of hepatitis B globally, rising initiatives to increase awareness about hepatitis B, and increasing funding for the development of vaccines. In addition, the high prevalence of hepatitis B globally is anticipated to boost the growth of the market as well.
The hepatitis B vaccines market analysis includes end-user segment, type segment, and geographical landscapes.
The hepatitis b vaccines market is segmented as below:
By End-user
- Adult
- Pediatric
By Type
- Mono Vaccines
- Combination Vaccines
By Geographical Landscapes
- North America
- Europe
- Asia
- ROW
This study identifies the rising awareness of immunization in low- and middle-income countries as one of the prime reasons driving the hepatitis B vaccine market growth during the next few years. Also, new technological advancements and a strong pipeline will lead to sizable demand in the market.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The report on the hepatitis b vaccines market covers the following areas:
- Hepatitis b vaccines market sizing
- Hepatitis b vaccines market forecast
- Hepatitis b vaccines market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hepatitis B vaccines market vendors that include Bharat Biotech Ltd., Dynavax Technologies Corp., GlaxoSmithKline Plc, Indian Immunologicals Ltd., KM Biologics Co. Ltd., LG Chem Ltd., Merck & Co. Inc., Sanofi, Serum Institute of India Pvt. Ltd., and Shenzhen Kangtai Biological Products Co. Ltd. Also, the hepatitis B vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.
This market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by End-user
Market Segmentation by Type
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global hepatitis B vaccines market: Bharat Biotech Ltd., Dynavax Technologies Corp., GlaxoSmithKline Plc, Indian Immunologicals Ltd., KM Biologics Co. Ltd., LG Chem Ltd., Merck & Co. Inc., Sanofi, Serum Institute of India Pvt. Ltd., and Shenzhen Kangtai Biological Products Co. Ltd.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the rising awareness of immunization in low- and middle-income countries."
According to the report, one of the major drivers for this market is the high prevalence of hepatitis B globally.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bharat Biotech Ltd.
- Dynavax Technologies Corp.
- GlaxoSmithKline Plc
- Indian Immunologicals Ltd.
- KM Biologics Co. Ltd.
- LG Chem Ltd.
- Merck & Co. Inc.
- Sanofi
- Serum Institute of India Pvt. Ltd.
- Shenzhen Kangtai Biological Products Co. Ltd.
